-
My Account
co-presented by
ASSOCIATE SPONSORS
In App
My Account
co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
BSE Live
Mar 14, 16:00Prev. Close
396.55
Open Price
395.10
Bid Price (Qty.)
395.00 (1000)
Offer Price (Qty.)
396.55 (187)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Claris Lifesciences (in Rs. Cr.) | Dec 06 | Dec 05 | |
| 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||
| SHAREHOLDER'S FUNDS | |||
| Equity Share Capital | 89.69 | 29.11 | |
| Total Share Capital | 89.69 | 29.11 | |
| Reserves and Surplus | 154.91 | 65.83 | |
| Total Reserves and Surplus | 154.91 | 65.83 | |
| Total Shareholders Funds | 244.60 | 94.94 | |
| NON-CURRENT LIABILITIES | |||
| Long Term Borrowings | 171.41 | 75.56 | |
| Deferred Tax Liabilities [Net] | 21.96 | 13.62 | |
| Other Long Term Liabilities | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 193.37 | 89.18 | |
| CURRENT LIABILITIES | |||
| Short Term Borrowings | 0.00 | 0.00 | |
| Trade Payables | 0.00 | 0.00 | |
| Other Current Liabilities | 145.70 | 59.69 | |
| Short Term Provisions | 15.70 | 12.37 | |
| Total Current Liabilities | 161.40 | 72.06 | |
| Total Capital And Liabilities | 599.37 | 256.18 | |
| ASSETS | |||
| NON-CURRENT ASSETS | |||
| Tangible Assets | 224.24 | 121.01 | |
| Intangible Assets | 0.41 | 0.00 | |
| Capital Work-In-Progress | 71.85 | 15.04 | |
| Other Assets | 0.00 | 0.00 | |
| Fixed Assets | 296.51 | 136.04 | |
| Non-Current Investments | 12.39 | 8.85 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.05 | |
| Total Non-Current Assets | 308.89 | 144.95 | |
| CURRENT ASSETS | |||
| Current Investments | 0.00 | 0.00 | |
| Inventories | 58.45 | 44.61 | |
| Trade Receivables | 117.96 | 32.47 | |
| Cash And Cash Equivalents | 76.43 | 10.88 | |
| Short Term Loans And Advances | 37.64 | 23.26 | |
| OtherCurrentAssets | 0.00 | 0.00 | |
| Total Current Assets | 290.48 | 111.23 | |
| Total Assets | 599.37 | 256.18 | |
| OTHER ADDITIONAL INFORMATION | |||
| CONTINGENT LIABILITIES, COMMITMENTS | |||
| Contingent Liabilities | 65.71 | 60.44 | |
| CIF VALUE OF IMPORTS | |||
| Raw Materials | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | |||
| Expenditure In Foreign Currency | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||
| Dividend Remittance In Foreign Currency | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | |||
| FOB Value Of Goods | -- | -- | |
| Other Earnings | -- | -- | |
| BONUS DETAILS | |||
| Bonus Equity Share Capital | -- | -- | |
| NON-CURRENT INVESTMENTS | |||
| Non-Current Investments Quoted Market Value | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | |
| CURRENT INVESTMENTS | |||
| Current Investments Quoted Market Value | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- |
03.12.2017
17.10.2017
31.07.2017
US FDA conducts surprise audit at Claris Life's Ahmedabad unit
27.07.2017
Claris completes injectables biz sale, to inform about transfer to shareholders by Oct
